From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Whether it's heat on a travel day or an unreliable hotel fridge, keeping insulin at the right temperature is a constant challenge when you're away from home
Both compounded and brand-name GLP-1 medications are available in multi-dose vials
Colorectal cancer stem cells: From the crypt to the clinic
Why In News
266 Faraji, F., Zarinfar, N., Zanjani, A
